69
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
6990.HK · HKSE
$460.20 -4.36% (-$21.00)
1M -7.90%
Market Cap ¥95.5B
P/E Ratio -
Div. Yield -
ROE 10.25%
Piotroski F-Score Moderate
4/9Valuation
0 /100
Expensive P/B 19.63x
P/S 42.43x
EV/FFO N/A
Growth
100 /100
Growing Rev. growth 36.79%
FCF growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Net margin 18.59%
Op. margin 16.35%
FCF margin 14.64%
Quality
5 /100
Poor ROE 10.25%
ROA 6.99%
Asset turnover 0.38x
Debt
100 /100
Low Current ratio 5.13x
Debt/Equity 0.02x
Net debt/EBITDA N/A
Stability
25 /100
Unstable Rev. volatility 44.70%
EPS volatility 49.62%
Profitable years 0
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre 6990.HK
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Jun You Ge
Employees
2,300
Headquarters
Chengdu
Evenimente viitoare
29 MAR.
Earnings
Upcoming earnings report